kidney cancer

by Estonian Research Council edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes Variability between individual radiologists’ measurements. Credit: Communications Medicine (2025). DOI: 10.1038/s43856-025-01264-0 Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine. Diagnosing kidney cancer relies on computed tomography (CT) scans and the use of contrast agents. These

by UT Southwestern Medical Center edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes PT2399/belzutifan disrupts HIF-2α binding to HIF-1β, thereby blocking its ability to bind DNA and stimulate the production of PTHrP, the hormone responsible for calcium induction in kidney cancer patients. Credit: UT Southwestern Medical Center Elevated calcium levels in the blood—a complication of kidney cancers known